Cisplatin resistance in an ovarian cancer model is mediated by microtubule dynamics regulator TPPP3 in synergy with tubulin code rewiring
Cell Reports · 2026
DOI: 10.1016/j.celrep.2026.117414 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2026. Verfasst von Sachi Horibata und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA; Precision …. Hauptthemen laut MEDLINE: Cisplatin, Ovarian Neoplasms, Microtubules, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, Intramural NIH HHS, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA; Precision Health Program, Michigan State University, East Lansing, MI 48824, USA…
- Cell Biology and Biophysics Unit, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.
- Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
- Computational Genomics and Bioinformatics Branch, Center for Biomedical Informatics & Information Technology, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, USA.
- Precision Health Program, Michigan State University, East Lansing, MI 48824, USA; Department of Pharmacology and Toxicology, College of Human Medicine, Michigan State University, East Lansing, MI 48824, USA.
- Quantitative Bio Element Analysis and Mapping (QBEAM) Center, Michigan State University, East Lansing, MI 48824, USA.
Förderung
- NIGMS NIH HHS
- Intramural NIH HHS
- Japan Society for the Promotion of Science
- U.S. Department of Health and Human Services
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institute of Neurological Disorders and Stroke
- National Institutes of Health
- Michigan State University
Zitieren
APA
Horibata, S., Mahalingan, K. K., Patel, R., Fan, Y., Hotz, J. M., Ponton-Almodovar, A., MacRenaris, K., Li, Y., Meerzaman, D., Gottesman, M. M., & Roll-Mecak, A. (2026). Cisplatin resistance in an ovarian cancer model is mediated by microtubule dynamics regulator TPPP3 in synergy with tubulin code rewiring. Cell Reports. https://doi.org/10.1016/j.celrep.2026.117414
Vancouver
Horibata S, Mahalingan KK, Patel R, Fan Y, Hotz JM, Ponton-Almodovar A, et al. Cisplatin resistance in an ovarian cancer model is mediated by microtubule dynamics regulator TPPP3 in synergy with tubulin code rewiring. Cell Reports. 2026. doi:10.1016/j.celrep.2026.117414
BibTeX
@article{Horibata2026,
author = {Horibata, Sachi and Mahalingan, Kishore K and Patel, Ruchi and Fan, Yu and Hotz, Jordan M and Ponton-Almodovar, Adriana and MacRenaris, Keith and Li, Yan and Meerzaman, Daoud and Gottesman, Michael M and Roll-Mecak, Antonina},
title = {Cisplatin resistance in an ovarian cancer model is mediated by microtubule dynamics regulator TPPP3 in synergy with tubulin code rewiring},
journal = {Cell Reports},
year = {2026},
doi = {10.1016/j.celrep.2026.117414}
}
EUVIMED